We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Platelet Volume Related to Geriatric Patient In-Hospital Mortality

By LabMedica International staff writers
Posted on 28 Aug 2019
Print article
Image: The BC-5800 hematology autoanalyzer (Photo courtesy of Mindray).
Image: The BC-5800 hematology autoanalyzer (Photo courtesy of Mindray).
Treatment of acute coronary syndrome involves inhibition of platelet activity and thrombus formation. Platelets play a significant part during myocardial infarction by enhancing microvascular obstruction and secreting vasoactive peptides.

Platelet reactivity is an important matter, and there is evidence that larger platelet size, measured as mean platelet volume (MPV), is associated with enhanced platelet activity. Higher MPVs are observed in patients with acute coronary syndromes compared with patients with stable angina or normal coronary arteries. Elevated MPV is associated with myocardial infarction and death.

Medical Biochemists and Cardiologists at the Recep Tayyip Erdoğan University (Rize, Turkey) enrolled 194 consecutive ST segment elevation myocardial infarction (STEMI) patients in a retrospective observational study between December 2012 and May 2014. The study population was divided into two groups on the basis of admission MPVs. The 49 patients in the high-MPV group had an MPV in the third tertile (>0.89 fL), and the 145 patients in the low-MPV group had an MPV in the lower two tertiles (≤0.89 fL).

The team collected blood samples in standardized tubes containing dipotassium EDTA, and all measurements were performed by an optical laser method with a Mindray BC-5800 hematology analyzer. High-sensitivity troponin T was quantified with a cobas e 411 analyzer. A 12-lead electrocardiogram was recorded in each patient just after hospital admission, and the myocardial infarction type was obtained from the electrocardiogram.

The scientists reported that patients in the high-MPV group were older, more of them had three-vessel disease, and they had higher in-hospital mortality. Patients with in-hospital death were older, had higher Gensini score, creatinine concentration, and MPV, and had lower high-density lipoprotein (HDL) cholesterol concentration. MPV, age, HDL cholesterol concentration, creatinine concentration, and Gensini score were found to be independent predictors of in-hospital death.

The authors concluded that their results suggest that high admission MPV levels are associated with increased in-hospital mortality in geriatric patients with STEMI undergoing primary percutaneous coronary intervention (PCI). The study was published on July 1, 2019, in the journal Cardiovascular Innovations and Applications.

Related Links:
Recep Tayyip Erdoğan University

Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Malondialdehyde HPLC Test
Malondialdehyde in Serum/Plasma – HPLC
New
Chagas Disease Test
LIAISON Chagas

Print article

Channels

Clinical Chemistry

view channel
Image: Professor Nicole Strittmatter (left) and first author Wei Chen stand in front of the mass spectrometer with a tissue sample (Photo courtesy of Robert Reich/TUM)

Mass Spectrometry Detects Bacteria Without Time-Consuming Isolation and Multiplication

Speed and accuracy are essential when diagnosing diseases. Traditionally, diagnosing bacterial infections involves the labor-intensive process of isolating pathogens and cultivating bacterial cultures,... Read more

Molecular Diagnostics

view channel
Image: Macrophages infected with mycobacterium tuberculosis (Photo courtesy of MIT)

New Molecular Label to Help Develop Simpler and Faster Tuberculosis Tests

Tuberculosis (TB), the deadliest infectious disease globally, is responsible for infecting an estimated 10 million people each year and causing over 1 million deaths annually. While chest X-rays and molecular... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.